A Science and Technology Blog
It was mistakenly assumed that as this disease spreads across the world, only the severe cases become apparent while most people would indeed be infected as reflected in sero epidemiology…
Studying adults aged 35 and 41 years who have received BCG vaccine and those who have not received it during childhood, Tel Aviv University researchers found no association between BCG…
Even as French researchers hypothesise that nicotine reduces the risk of novel coronavirus infection by preventing the virus from binding to a different receptor (nicotinic acetylcholine receptor or nAChR) and…
The study sheds light on how cytokine storm is associated with severe COVID-19 disease. Compared with patients with moderate COVID-19 disease, those with severe disease had higher concentration of macrophages,…
ICMR’s insistence on an evidence-based approach to plasma therapy is a welcome change and is in stark contrast to the cavalier manner in which it approved hydroxychloroquine as a prophylaxis…
After displaying extreme reluctance to admit community transmission despite having over 67,000 cases and the nature of the virus spread, India has finally decided to confirm community spread by testing 30,000…
In a first, NIV Pune has developed an ELISA test to detect IgG antibodies that are developed in response to infection by novel coronavirus. The ELISA test, to be manufactured…
On May 8, the Health Ministry’s revised policy said no testing is needed before discharging mild and moderate COVID-19 cases from dedicated facility. The decision was apparently taken based on…
